DAVIES, Julian,MAGRINI, Fabio,MARTIN, Andrea Paula,MOZAFFARIAN, Neelufar,PATEL, Chetankumar Natvarlal,SCHROEDER, Oliver
申请号:
ES15764397
公开号:
ES2774422T3
申请日:
2015.03.13
申请国别(地区):
ES
年份:
2020
代理人:
摘要:
The invention relates to engineered, humanized antibodies that have high binding affinity for and neutralize human IL-21, methods of using the antibodies to treat conditions in which antagonism or neutralization of the effects of IL-21 is warranted, such as autoimmune conditions, compositions and methods for recombinantly producing the antibodies, and pharmaceutical compositions comprising the antibodies.